Source:http://linkedlifedata.com/resource/pubmed/id/20946951
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
10
|
pubmed:dateCreated |
2011-4-25
|
pubmed:abstractText |
Our previous work showed that immunization of rabbits with 4-hydroxy-2-nonenal-modified Ro60 (HNE-Ro60) accelerates autoimmunity. We extended this model into mice, hypothesizing that the severity of autoimmunity would be dependent on the degree of HNE modification of Ro60. Five groups of BALB/c mice (10/group) were used. Group I was immunized with Ro60. Groups II to IV were immunized with Ro60 modified with 0.4 mM (low), 2 mM (medium), and 10 mM (high) HNE, respectively. Group V controls received Freund's adjuvant. A rapid abrogation of tolerance to Ro60/La antigens occurred in mice immunized with HNE-modified Ro60, especially in the low and medium HNE-Ro60 groups. Lymphocytic infiltration and significantly high decrement in salivary flow (37%) compared to controls was observed only in the high HNE-Ro60 group, suggesting induction of a Sjögren syndrome-like condition in this group. Anti-dsDNA occurred only in mice immunized with medium HNE-Ro60. This group did not have a significant decrement in salivary flow, suggesting induction of a systemic lupus erythematosus-like manifestation in this group. Significantly high antibodies to Ro60 were found in saliva of mice in the low and medium HNE-Ro60 and the Ro60 groups, as well as anti-HNE Ro60 in the low and medium HNE-Ro60 groups. Understanding the mechanism of this differential induction may help discriminate between these two autoimmune diseases.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1873-4596
|
pubmed:author |
pubmed-author:AsfaSimaS,
pubmed-author:BachmannMichaelM,
pubmed-author:CartellieriMarcM,
pubmed-author:D'SouzaAnilA,
pubmed-author:DorriYaserY,
pubmed-author:HensleyKennethK,
pubmed-author:IqbalSaqibS,
pubmed-author:KurienBiji TBT,
pubmed-author:MathiasKristenK,
pubmed-author:MatsumotoHiroyukiH,
pubmed-author:PorterAndrewA,
pubmed-author:ScofieldR HalRH,
pubmed-author:SinghAnilA
|
pubmed:copyrightInfo |
Published by Elsevier Inc.
|
pubmed:issnType |
Electronic
|
pubmed:day |
15
|
pubmed:volume |
50
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1222-33
|
pubmed:meshHeading |
pubmed-meshheading:20946951-Aldehydes,
pubmed-meshheading:20946951-Animals,
pubmed-meshheading:20946951-Autoimmunity,
pubmed-meshheading:20946951-Female,
pubmed-meshheading:20946951-Lipid Peroxidation,
pubmed-meshheading:20946951-Lupus Erythematosus, Systemic,
pubmed-meshheading:20946951-Mice,
pubmed-meshheading:20946951-Mice, Inbred BALB C,
pubmed-meshheading:20946951-Ribonucleoproteins,
pubmed-meshheading:20946951-Salivary Glands,
pubmed-meshheading:20946951-Sjogren's Syndrome
|
pubmed:year |
2011
|
pubmed:articleTitle |
Degree of modification of Ro60 by the lipid peroxidation by-product 4-hydroxy-2-nonenal may differentially induce Sjögren syndrome or systemic lupus erythematosus in BALB/c mice.
|
pubmed:affiliation |
Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, N.I.H., Extramural
|